Antibody-immune agonist conjugate and applications thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11717576
APP PUB NO 20220378930A1
SERIAL NO

17689198

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENEQUANTUM HEALTHCARE (SUZHOU) CO LTDRUOSHUI RD 398 5TH FLOOR BUILDING D SUZHOU INDUSTRIAL PARK 215123

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Chong Suzhou, CN 94 382
Qin, Gang Suzhou, CN 24 78
Song, Paul H Suzhou, CN 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 8, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 8, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 8, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00